I-Tenofovir, ebizwa nangokuthi i-tenofovir disoproxil fumarate, isichiza se-anti-antial sokunakekelwa kwesifo esingapheliyo sesifo se- hepatitis B (HBV) kubantu abadala kunye nabantwana abaneminyaka eli-12 nangaphezulu. Ikwasetyenziswa kwakhona, ngokudibene nezinye iziyobisi, ukunyanga igciwane lesandulela ngculazi okanye i- HIV . Ithengiswa phantsi kwegama le-Viread ngeGiliyadi Sciences, Inc.
Ingaba isebenza kanjani
I-HBV yintsholongwane engekho isifo, ithetha ukuba intsholongwane ngokwayo ayilonakalisi ngqo isibindi.
Kunoko, xa umzimba ukhulelwe yi-HBV, isistim somzimba sokulwa nomzimba sikhombisa ukuhlaselwa kwintsholongwane kwaye kubangele umonakalo onobungozi ngendlela yokuvuvukala nokulimala esibindi. I-Tenofovir inxalenye yeklasi yamachiza ebizwa ngokuba yi-nucleoside reverse transcriptase inhibitors ( NRTIs ). Ezi zisebenza ngokunciphisa inani legciwane lesifo se-hepatitis B egazini, okokugcina kugcinwe ukuphendula komzimba. Ayinakuphilisa i-hepatitis B, ayinakuyithintela ingxaki yesifo njengesijikelezo sesibindi okanye umdlavuza wesibindi, kwaye ayiyi kuthintela ukusasazeka kwintsholongwane kwabanye.
Amanye amagama kwiTenofovir
Akukho ziyobisi ezikhoyo ezikhoyo.
Impumelelo
I-Tenofovir iyakwazi ukuphatha i-hepatitis B ngempumelelo kakhulu kwabanye abantu. Kwezinye iimeko, i-tenofovir iyasebenza ngakumbi kune-adefovir kunye ne-lamivudine. Uphando olutsha lubonisa ukuba i-tenofovir yonyango ekhuselekileyo neyinkqubo yexesha elide kwi-HBV, ingakumbi kubantu abaye batyalela ukumelana ne-lamivudine.
Ukongezelela, olu phando lubonisa ukuba lukhokelela kwimiphumo emibini echaphazelekayo yezintso kwaye akukho nkunkuma echaphazelekayo yonyango.
Indlela yokuThatha
I-Viread ipilisi ye-300 mg. Ukugula okungapheliyo kwe- hepatitis B, i-dosing yokuqhelekileyo kubantu abadala i-300 mg kanye ngosuku kwaye inokuthathwa okanye ngaphandle kokutya. Le milingo ingatshintsha abantu abaneengxaki zeengtso.
Iindleko
Unyaka owodwa wonyango kunye ne-tenofovir inokubiza ngokulula ngaphezu kwama-8,000. Nangona kunjalo, iindleko zeziyobisi ziyahluka ngokuxhomekeke kwizinto ezininzi, njengokuba unomshuwalense wezempilo , apho uhlala khona kwaye yiyiphi ikhemisi oyisebenzisayo.
Imiphumela
Iziphumo ezichaphazelekayo ze-tenofovir ziquka:
- Uhudo
- Intloko
- Ukuxinezeleka
- Rash
- Ukutshiza
- Fever
- Ubunzima bokulala okanye ukulala
- Gesi
- Ukuhla ukusinda
Ukongezelela, iingxaki ezinzulu zesibindi, kunye nesimo esibizwa ngokuba yi-lactic acidosis, sinokuphuhliswa ngokukhawuleza kwizigulane ezithatha i-tenofovir. Ukuba ufumana iimpawu ezilandelayo ngelixa uthatha i-tenofovir, kufuneka ubizele ugqirha wakho okanye ufune unyango lwengxamisekileyo:
- Ukupheka isicatshulwa okuqhubekayo kunye / okanye ukuhlanza
- Intlungu / iintlungu zesisu
- Pale izitulo
- Umchamo omnyama
- I-jaundice (ukuphuka kwamehlo kunye / okanye isikhumba)
- Ukukhathala okukhulu
- Ukuphefumla okukhawulezayo okanye okunzima
- Ukulala
- Intlungu yesisu kunye / okanye ubuthathaka
- Isikhumba sobandayo
Ngubani ongafanele athathe iTenofovir
Nabani na ochasayo kwi-tenofovir akufanele athathe le nkunkuma. Kwakhona kubalulekile ukwazi isimo sakho se-HIV kuba ukuthatha i-tenofovir kunokunyanzelisa kakhulu ukuphatha i-HIV. Ukuba unayo i-HIV kunye ne-HBV, ungaqalisi unyango lwentsholongwane ngaphandle kokubonisana nodokotela oye wafumana unyango lwezo zibini. I-Tenofovir ikwahlulelwa njengesicatshulwa seB b ukusetyenziswa xa ukhulelwa, oku kuthetha ukuba akukho bungqina obubonisa ukuba kuyingozi kumama okhulelwe okanye umntwana wakhe.
> Umthombo:
US Food and Drug Administration. I-Hepatitis Treaty.
I-UpToDate, iBasow, iDS (Ed), UpToDate, i-Waltham, MA, 2010.